Pacific Biosciences and Cergentis have presented the combination of TLA and the Pacific Biosciences SMRT sequencing technology during a poster session at the prestigious AGBT Precision Health meeting which took place from 5-7 September 2019.
September 13, 2018
Cergentis & Princess Máxima Center collaborate on MRD test development for leukemia and solid tumours
June 13, 2018
Cergentis’ CEO invited to present TLA technology at ACTIP meeting in Dusseldorf